MYRIAD GENETICS INC MYRIAD GENE (0K3W.L) Financials
0K3W.L Assets vs Liabilities
No data available :(
0K3W.L Free Cash Flow and Stock based compensation
No data available :(
0K3W.L Net Income
No data available :(
0K3W.L Cash and Debt
No data available :(
0K3W.L Shares Outstanding
0K3W.L Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2021-09-30 | 3.0 million | - | - | - |
| 2021-06-30 | 4.5 million | - | - | - |
| 2021-03-31 | 7.1 million | - | - | - |
| 2020-12-31 | 7.1 million | - | - | - |
0K3W.L Cost of Revenue
No data available :(
0K3W.L
Price: $25.48
52 week price:
Earnings Per Share: -0.11 USD
P/E Ratio: -215.23
Exchange: LSE
Sector: Healthcare
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Market Capitalization: 18.4 million